There was a trend towards the single agents also reducing the tumor burden, however, the data did not reach statistical significance (~33 and ~30 nodules in response to 2DG and carboplatin, respectively; Figure 4 B, right).
← all excerpts
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
1
—
—